Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems. The company offers medical instrumentation products, including endoscopes and endocouplers. It also provides components and assemblies, which are designed for industrial and military use. Company was incorporated in 1982 and is based in Gardner, Massachusetts.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $10.7M | $15.7M | $21.0M | $19.1M | $19.1M |
| Gross profit | $3.4M | $4.9M | $7.7M | $5.8M | $3.4M |
| Operating income | -$905,583.00 | -$1.5M | -$638,548.00 | -$2.7M | -$5.6M |
| Net income | -$102,835.00 | -$928,416.00 | -$144,613.00 | -$3.0M | -$5.8M |
| Diluted EPS | -$0.01 | -$0.18 | -$0.03 | -$0.49 | -$0.85 |
| Operating cash flow | $46,550.00 | -$933,371.00 | -$81,090.00 | -$2.7M | -$3.5M |
| Free cash flow | -$29,374.00 | -$1.0M | -$97,874.00 | -$3.0M | -$3.8M |
| Gross margin | 32.2% | 31.4% | 36.8% | 30.3% | 17.8% |
| Operating margin | -8.5% | -9.7% | -3.0% | -14.3% | -29.1% |
| Net margin | -1.0% | -5.9% | -0.7% | -15.4% | -30.3% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7M | $4.2M | $4.5M | $4.2M | $6.2M | $6.7M | $7.4M | $8.7M |
| Gross profit | $1.0M | $1.1M | $1.1M | $417,975.00 | $799,186.00 | $946,358.00 | $204,660.00 | $2.1M |
| Operating income | -$1.4M | -$1.2M | -$910,021.00 | -$2.0M | -$1.4M | -$1.6M | -$1.7M | -$64,462.00 |
| Net income | -$1.4M | -$1.3M | -$969,681.00 | -$2.1M | -$1.4M | -$1.6M | -$1.8M | -$108,283.00 |
| Diluted EPS | -$0.23 | -$0.21 | -$0.15 | -$0.30 | -$0.19 | -$0.21 | -$0.23 | -$0.01 |
| Operating cash flow | -$976,014.00 | -$318,622.00 | -$786,809.00 | -$1.9M | -$569,235.00 | $78,227.00 | -$256,079.00 | -$723,258.00 |
| Free cash flow | -$987,645.00 | -$342,971.00 | -$816,630.00 | -$2.0M | -$615,459.00 | — | — | — |
| Gross margin | 21.7% | 26.6% | 23.6% | 10.0% | 12.9% | 14.2% | 2.8% | 23.6% |
| Operating margin | -28.8% | -29.7% | -20.1% | -48.7% | -21.9% | -23.9% | -23.6% | -0.7% |
| Net margin | -29.9% | -31.2% | -21.4% | -50.1% | -22.7% | -24.5% | -24.2% | -1.2% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-31 | COLL WAYNE M· Chief Financial Officer | Award | 1,568 | $3.99 | $6,248.48 | filing |
| 2026-03-30 | TRAUT JOSEPH· Chief Operating Officer | Buy | 41,666 | $3.60 | $149,997.60 | filing |
| 2026-03-30 | COLL WAYNE M· Chief Financial Officer | Buy | 20,833 | $3.60 | $74,998.80 | filing |
| 2026-03-30 | Forkey Joseph Norman· Chief Executive Officer | Buy | 1,388 | $3.60 | $4,996.80 | filing |
| 2026-03-12 | Miclot Andrew J. | Tax withholding | 6,372 | $4.52 | $28,801.44 | filing |
| 2026-03-12 | Miclot Andrew J. | Option exercise | 20,000 | $1.44 | $28,800.00 | filing |
| 2025-09-30 | COLL WAYNE M· Chief Financial Officer | Award | 1,370 | $6,250.00 | $8.6M | filing |
| 2025-06-30 | COLL WAYNE M· Chief Financial Officer | Award | 1,405 | $6,250.00 | $8.8M | filing |
Latest 8 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.